Article
Systemic or topical application of plasminogen activator inhibitor with extended half-life (VLHL PAI-1) reduces bleeding time and total blood loss.
International journal of molecular medicine - 1 Oct 2010
Jankun Jerzy, Keck Rick, Selman Steven H, Skrzypczak-Jankun Ewa
Abstract excerpt
Civilian and military trauma patients consist of a disproportional number of young people, causing a considerable burden to society in terms of disability and premature death. Hemorrhage is a leading cause of mortality in this group of patients and the novel methods to reduce bleeding would be we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.